James P. Allison, PhD, director, immunotherapy platform, The University of Texas MD Anderson Cancer Center, discusses the future of immune checkpoint strategies.
James P. Allison, PhD
Articles by James P. Allison, PhD
James P. Allison, PhD, director, immunotherapy platform, The University of Texas MD Anderson Cancer Center, discusses the potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.
Latest Updated Articles
The Potentiation of Checkpoint Blockade With Oncolytic VirusPublished: June 4th 2014 | Updated:
Future Immune Checkpoint StrategiesPublished: August 18th 2014 | Updated: